General Information
Revision date
2022-07-22
Product name
ZANTAC INJECTION
Product Synonyms
ZANTAC INJECTION 25 MG/ML * ZANTAC INJECTION 25 MG/ML (NZ) * ZANTAC INJECTION
CAS No.
66357-59-3
1.2.1 Relevant identified uses
the purpose intended. Consumers/Patients should consult prescribing information/package insert/product label or consult their chemist or physician Specific restrictions for use of No other uses are advised
supplier name
GlaxoSmithKline US
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Skin corrosion/irritation Category 3 Sensitization, skin Category 1
Environmental hazards
Not classified.
2.2 Label elements
Hazard symbol(s)
Signal word
Warning
Hazard statements
Causes mild skin irritation. May cause an allergic skin reaction.
Prevention
Avoid breathing mist/vapours. Contaminated work clothing must not be allowed out of the workplace. Wear protective gloves.
Response
IF ON SKIN Wash with plenty of soap and water. Specific treatment (see instruction on this label). If skin irritation or rash occurs Get medical advice/attention. Take off contaminated clothing and wash it before reuse.
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
2.5 % of the mixture consists of component(s) of unknown acute dermal toxicity. 2.5 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 2.5 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
